We believe screening for MGD and other ocular surface conditions shouldn’t be hard nor expensive, for both operators and patients alike. That’s why we invested heavily in building a diagnosis+screening device that could tackle this challenge easily, quickly and effectively for all—introducing me-check®.
Both eyes are tested—e.g., through a 2D/3D Meibography for MGD/DED. The average eye test is conducted within 5’, start to finish, with no harm nor discomfort for the patient. The result is repeatable and consistent, and a wide variety of tests are available (i.e., Demodex, OSE, OSDI-6, Interferometry, Blink Quality).
The OSDI-6 questionnaire is conducted to complete the results of the eye test. The questionnaire is conducted by the practitioner, requires no more than 5’ and the results are input straight into me-check® OS.
The me-check® OS provides a comprehensive overview of the patient’s conditions leveraging Dr. Pult’s scale for MGD/DED.
If possible, diagnosis is seamlessly loaded straight into any Espansione solution—e.g., eye-light® , meibomask® , my-mask® for treatment. If the me-check® workflow is brought forward without the possibility of an immediate treatment, the diagnosis is sent over directly from the software via email to whoever will treat the patient.
